Metraipolis › archive › dc_da2162397027

Sodium-Glucose Cotransporter-2 Inhibitors in Valvular Heart Disease: From Mechanistic Insights to Clinical Application — Europe PMC PMID:42769931

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42769931
DOI
10.1016/j.jscai.2026.105568
License (as archived)
solo-consultazione
Archived
2026-10-17T04:07:13.666Z
SHA-256 of the archived text
e9f6a9f5e73ce5e635a3218921b4d3ef261604020e5620f053681e9e2ee856fb
Stable URL of this page
https://metraipolis.com/documento/dc_da2162397027

How to cite

Sodium-Glucose Cotransporter-2 Inhibitors in Valvular Heart Disease: From Mechanistic Insights to Clinical Application — Europe PMC PMID:42769931 — Europe PMC (en), https://europepmc.org/article/MED/42769931 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da2162397027 (Metraipolis archive dc_da2162397027, sha256 e9f6a9f5e73ce5e635a3218921b4d3ef261604020e5620f053681e9e2ee856fb)
BibTeX
@misc{dcda2162397027,
  title = {Sodium-Glucose Cotransporter-2 Inhibitors in Valvular Heart Disease: From Mechanistic Insights to Clinical Application — Europe PMC PMID:42769931},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42769931},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da2162397027; sha256 e9f6a9f5e73ce5e635a3218921b4d3ef261604020e5620f053681e9e2ee856fb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42769931. Agents can read the archived copy with the MCP tool read_document.